On Monday, Shares of Master card Inc (NYSE:MA), lost -0.70% to $97.98.
MasterCard (MA), declared its participation in the following investor conference in the month of December:
On Wednesday, December 2, Martina Hund-Mejean, chief financial officer, will present at the J.P. Morgan FinTech & Specialty Finance Forum in New York. The negotiation will start at 1:30 p.m. Eastern Time and last for about 40 minutes.
MasterCard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally. The company facilitates the processing of payment transactions, counting authorization, clearing, and settlement, in addition to delivers related products and services.
Shares of Wendys Co (NASDAQ:WEN), inclined 0.29% to $10.51, during its last trading session.
Finding a way to give back this Giving Tuesday, a global day dedicated to giving back, has never been sweeter than with Wendy’s National Frosty Key Tag Program. Until the end of the year, customers can buy a Frosty Key Tag for $1 and receive a free Jr. Frosty with every purchase until December 31, 2016. Proceeds from Frosty Key Tag sales will go to assist find families for children waiting in foster care through the Dave Thomas Foundation for Adoption®, which is dedicated to finding permanent homes for the more than 130,000 children waiting in North America’s foster care systems.
Wendy’s Founder Dave Thomas was himself adopted and founded the Dave Thomas Foundation for Adoption in 1992.
“We hope consumers will embrace Giving Tuesday and the holiday season as a time to make a difference in the lives of children waiting in foster care,” said Liz Geraghty, Wendy’s vice president of brand marketing. “It’s unacceptable that 130,000 children in North America won’t have permanent, loving families to spend the holidays with, and we are passionately working to change this reality so that all children can have the childhood they deserve.”
The Wendy’s Company, through its auxiliaries, owns and franchises Wendy’s restaurant system. The company is involved in operating, developing, and franchising a system of quick-service restaurants. As of May 26, 2015, its restaurant system comprised about 6,500 franchised and company-operated restaurants worldwide.
Finally, Shares of Cytori Therapeutics Inc (NASDAQ:CYTX), ended its last trade with -1.25% loss, and closed at $0.364.
Cytori Therapeutics, declared the publication of preclinical data demonstrating that Cytori Cell Therapy can promote burn wound healing via topical spray delivery, achieving similar effects to local injection. The option for spray delivery expands the potential utility and offers greater ease of use for Cytori Cell Therapy in the burn setting. The study was performed with support from the Biomedical Advanced Research and Development Authority (BARDA), and is described in a paper entitled “Adipose-Derived Regenerative Cell Therapy for Burn Wound Healing: A Comparison of Two Delivery Methods”.
“These data clearly show that topical spray delivery represents an effective solution to administer Cytori Cell Therapy and potentially optimize standard of care in fragile burn patients,” said Dr. Mayer Tenenhaus, a plastic surgeon from UCSD Burn Center.
The purpose of this study was to compare the effects of topical spray delivery and local injection of Cytori Cell Therapy in a porcine model of thermal burn. Importantly, the data demonstrated that administration by topical spray led to statistically noteworthy improvement over control in epithelialization, blood vessel density, and inflammatory cell infiltration. Results with topical spray were equivalent to those with local injection suggesting that delivery via a spraying mechanism is a viable and favorable alternative to other, more cumbersome delivery routes.
Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy compriseing of a heterogeneous population of specialized cells, counting stem cells for the treatment of patients with scleroderma hand dysfunction, orthopedic disorders, cardiovascular disease, urinary incontinence, and thermal burns combined with radiation injury.